🇺🇸 FDA
Pipeline program

OMC and pseudo-SDT

Ye Tian PAD

Phase 2 other completed

Quick answer

OMC and pseudo-SDT for Peripheral Arterial Disease is a Phase 2 program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Peripheral Arterial Disease
Phase
Phase 2
Modality
other
Status
completed

Clinical trials